When these potential parameters were evaluated, SP-A appeared to be the most promising marker for COPD since its levels were elevated after long-term smoking and also in COPD as compared to the situation in chronic smokers. This evidence concerns the gene SFTPA2 and chronic obstructive pulmonary disease.